| Serial Number | 97108638 |
| Word Mark | WELTRUZA |
| Filing Date | Thursday, November 4, 2021 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, September 6, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | pharmaceutical preparations for the prevention and treatment of alzheimer's disease; pharmaceutical preparations for the prevention and treatment of depression; pharmaceutical preparations for the prevention and treatment of psychological disorders; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of osteoporosis; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; pharmaceutical preparations for the prevention and treatment of aids-related disorders; pharmaceutical preparations that support, encourage and promote bone strength; pharmaceutical preparations that support, encourage and promote bone health; pharmaceutical preparations used in the treatment of bone disorders and bone diseases; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, fertility enhancement preparations; pharmaceutical preparations, namely, hormone replacement therapy preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical agents affecting the central nervous system; pharmaceutical agents affecting circulatory systems; pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting urogenital organs; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of neurological disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 15, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Teva Pharmaceuticals International GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Jona 8645 CH |
| Event Date | Event Description |
| Tuesday, September 6, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, September 6, 2022 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Tuesday, September 6, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, February 16, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 16, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 16, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 16, 2022 | ASSIGNED TO EXAMINER |
| Monday, November 15, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, November 8, 2021 | NEW APPLICATION ENTERED IN TRAM |